Table 1 Clinical data at the time of diagnosis for dogs with epilepsy, idiopathic, and structural epilepsy
Variables | Number of dogs | ||
|---|---|---|---|
Epilepsy (n = 358) | IdE (n = 172) | StE (n = 76) | |
Gender | |||
Male [Neuter] | 193 (54 %) [71 (20 %)] | 97 (56 %) [37 (22 %)] | 34 (45 %) [14 (18 %)] |
Female [Neuter] | 165 (46 %) [79 (22 %)] | 75 (44 %) [41 (24 %)] | 42 (55 %) [16 (21 %)] |
Body weight (kg) | |||
Median | 6.0 | 6.2 | 5.9 |
Range | 1.0–54.0 | 1.3–37.8 | 1.0–39.5 |
Age at initial seizure onset (years) | |||
Median | 3.6 | 2.5 | 5.5 |
Range | 0.1–14.4 | 0.5–6.8 | 0.2–13.9 |
Neurological | |||
Normal or unremarkable | 117 (33 %) | 170 (99 %) | 24 (33 %) |
Deficits | 241 (67 %) | 2 (1 %) | 52 (67 %) |
Seizure frequency at first presentation (sz/month) | |||
Median | 2.0 | 1.2 | 4.0* |
Range | 0.1–37.0 | 0.1–37.0 | 0.1–30.0 |
Seizure type | |||
FES | 93 (26 %) | 52 (30 %)* | 10 (13 %) |
GES | 190 (53 %) | 78 (46 %) | 56 (74 %)* |
FEvG | 75 (21 %) | 42 (24 %) | 10 (13 %) |
Specific seizure pattern | |||
CS | 141 (39 %) | 53 (31 %) | 42 (54 %)* |
SE | 71 (20 %) | 31 (18 %) | 22 (29 %) |
AEDs used at first presentation | |||
None | 180 (51 %) | 99 (58 %) | 28 (37 %) |
Monotherapy | 137 (38 %) | 55 (32 %) | 38 (50 %) |
Polytherapy | 41 (11 %) | 18 (10 %) | 10 (13 %) |
Using other treatment | |||
No | 281 (78 %) | 159 (92 %) | 30 (41 %) |
Yes | 77 (22 %) | 13 (8 %) | 46 (59 %) |